Baldwin Brothers LLC Bristol Myers Squibb CO Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baldwin Brothers LLC holds 2,001 shares of BMY stock, worth $113,656. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,001

Previous 1,884 6.21%

Holding current value

$113,656

Previous $78,000 32.05%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $4,640 - $6,054	117 Added 6.21%	2,001 $103,000
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $298,252 - $392,655	-7,410 Reduced 79.73%	1,884 $78,000
Q4 2023 Jan 08, 2024	SELL	$48.48 - $57.85 $89,009 - $106,212	-1,836 Reduced 16.5%	9,294 $476,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $124,521 - $139,234	-2,151 Reduced 16.2%	11,130 $645,000
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $382 - $424	6 Added 0.05%	13,281 $849,000
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $26,218 - $29,737	-399 Reduced 2.92%	13,275 $920,000
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $724,929 - $858,418	10,586 Added 342.81%	13,674 $0
Q3 2022 Oct 14, 2022	BUY	$0.13 - $76.84 $69 - $41,339	538 Added 21.1%	3,088 $220,000
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $11,681 - $14,006	-190 Reduced 6.93%	2,550 $186,000
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $47,336 - $55,448	-800 Reduced 22.6%	2,740 $162,000
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $55,719 - $60,678	900 Added 34.09%	3,540 $237,000
Q1 2021 Apr 08, 2021	SELL	$59.34 - $66.74 $14,597 - $16,418	-246 Reduced 8.52%	2,640 $167,000
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $6,466 - $7,328	-112 Reduced 3.74%	2,886 $179,000
Q3 2020 Oct 16, 2020	BUY	$57.43 - $63.64 $72,074 - $79,868	1,255 Added 72.0%	2,998 $181,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $37,940 - $49,490	771 Added 79.32%	1,743 $112,000
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $14,969 - $17,748	-350 Reduced 26.48%	972 $49,000
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $139,571 - $154,335	-3,128 Reduced 70.29%	1,322 $60,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $23,552 - $28,083	-522 Reduced 10.5%	4,450 $213,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $57,975 - $75,180	-1,189 Reduced 19.3%	4,972 $259,000
Q3 2018 Oct 26, 2018	BUY	$55.19 - $62.25 $229,204 - $258,524	4,153 Added 206.82%	6,161 $383,000
Q2 2018 Jul 24, 2018	SELL	$50.53 - $62.98 $2,779 - $3,463	-55 Reduced 2.67%	2,008 $111,000
Q1 2018 Apr 16, 2018	BUY	$59.92 - $68.98 $21,631 - $24,901	361 Added 21.21%	2,063 $130,000
Q4 2017 Jan 24, 2018	SELL	$59.94 - $65.35 $37,582 - $40,974	-627 Reduced 26.92%	1,702 $104,000
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $128,630 - $148,450	2,329	2,329 $148,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Bristol Myers Squibb CO Transaction History